Self-hangIng Patient and Hyperbaric Oxygen Therapy _ SIPHON Study

ConditionSuicide
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Lille

About this trial

During an attempted hanging, patients present severe neurological distress that can lead to major neuropsychiatric sequelae. These sequelae are notably due to significant cerebral edema related to hanging. Hyperbaric Oxygen therapy is known to reduce cerebral edema and improve cerebral perfusion. The main objective of the study is to evaluate in patients who have attempted hanging without presenting cardio-respiratory arrest, the effect of one Hyperbaric Oxygen therapy session in addition to standard intensive care management on a potential reduction in short-term neurological sequelae. Patients will benefit from either standard management or standard management associated with one Hyperbaric Oxygen therapy session

Eligibility criteria

Qualifiers

Glasgow score < 13/15

Confusional syndrome

Psychomotor agitation Who most of the time require optimal neuroprotection by sedation and invasive mechanical ventilation for the purpose of protecting the airways.

Patient aged over 18 years,

Disqualifiers

Response time exceeded by > 6 hours from the hanging

Attempted hanging with immediate return to normal consciousness

Refusal of consent from the family or trusted person at the time of inclusion in the study,

Patients and/or families unable to understand the information provided

Trial design

Treatments tested in this trial

  • OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL

Treatment groups

50 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators